Thomas Jefferson University
Clinical trials sponsored by Thomas Jefferson University, explained in plain language.
-
New hope for tough blood cancers: testing a Triple-Drug attack
Disease control OngoingThis study is testing a new combination of three drugs—navitoclax, venetoclax, and decitabine—for patients with a high-risk type of blood and bone marrow cancer called myelodysplastic syndrome (MDS) that has come back or hasn't responded to standard treatments. The main goals are…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Can skipping midnight snacks fight cancer treatment side effects?
Disease control OngoingThis study is testing whether a phone-based coaching program can help men on hormone therapy for prostate cancer. Participants work with a coach to gradually extend their overnight fasting period, aiming for 16 hours each night, and report their progress via text messages. The go…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Common supplement studied to protect MS Patients' brains
Disease control ENROLLING_BY_INVITATIONThis study is testing whether N-acetyl cysteine (NAC), an antioxidant supplement, can help protect brain function in people with multiple sclerosis (MS). Researchers will use brain scans to measure changes in brain metabolism and inflammation in 55 MS patients who receive either …
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Pushing radiation limits for tough brain tumors
Disease control TerminatedThis early-stage study is testing whether higher doses of radiation can be safely given to patients with aggressive or returning brain tumors called meningiomas. Researchers are using advanced PET and MRI scans to precisely target the radiation while carefully monitoring for side…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Early trial tests new arsenal against stubborn blood cancer
Disease control OngoingThis early-stage study is testing the safety and best dose of a three-drug combination for patients with slow-growing non-Hodgkin's lymphoma that has returned or not responded to prior treatment. The drugs work together to help the immune system attack cancer cells and block a pr…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Triple-Threat attack on prostate cancer shows promise
Disease control OngoingThis early-stage trial is testing whether combining three different treatments is safe for men with aggressive prostate cancer. The approach uses a hormone-blocking drug (enzalutamide), radiation therapy, and standard hormone injections to attack the cancer from multiple angles. …
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Feb 27, 2026 15:05 UTC
-
Could a simple ultrasound scan replace prostate biopsies?
Diagnosis OngoingThis study is testing whether a special type of ultrasound can accurately find prostate cancer. Men scheduled for prostate removal surgery receive a safe, short-lived contrast agent and then have an ultrasound scan. Researchers will compare the ultrasound images to the actual pro…
Phase: PHASE3 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
Neck sensor could sound alarm before opioids stop Patient's breathing
Diagnosis ENROLLING_BY_INVITATIONThis study is testing a new wearable neck sensor designed to catch dangerous breathing slowdowns caused by opioid painkillers after surgery. Researchers will compare the sensor's readings to standard hospital monitors on 120 patients to see if it can accurately detect and even pr…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Mar 23, 2026 15:17 UTC
-
Can natural supplements give failing hearts a boost?
Symptom relief ENROLLING_BY_INVITATIONThis study is testing whether taking ketone or hawthorn extract supplements for about 8 weeks can help people with congestive heart failure. Researchers want to see if these supplements can improve how well the heart works and increase a person's ability to exercise. About 45 par…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Mar 31, 2026 12:10 UTC
-
New approaches to ease agony of broken ribs
Symptom relief OngoingThis study compares three different pain management approaches for adults aged 55+ with multiple broken ribs. Researchers want to see which method best reduces pain and opioid medication use while helping patients breathe better. The trial involves 24 hospitalized patients who wi…
Phase: PHASE4 • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
Zapping the spine: can electricity restore movement after paralysis?
Symptom relief TerminatedThis study is testing whether gentle electrical and magnetic stimulation applied to the skin over the spine can help improve movement and reduce muscle stiffness in people with long-term spinal cord injuries. Researchers will work with 10 participants to find the best stimulation…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Mar 17, 2026 13:10 UTC
-
Earbud therapy tested to calm Stressed-Out nurses and doctors
Symptom relief OngoingThis study is testing whether a special earbud device, which gently stimulates a nerve in the ear, can help reduce anxiety and emotional distress in healthcare workers. Researchers will enroll about 90 stressed healthcare professionals from Philadelphia to use the device for thre…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Mar 02, 2026 15:28 UTC
-
Doctors test virtual tool to improve prostate cancer genetics discussions
Knowledge-focused OngoingThis study is testing a web-based virtual meeting tool designed to help healthcare providers discuss prostate cancer genetics cases. Doctors and other providers use the tool to talk about genetic testing, personalized treatment options, and screening recommendations. Researchers …
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Stress and social factors may worsen liver disease in korean americans with hepatitis b
Knowledge-focused OngoingThis study aims to understand how stress, depression, and social factors might affect liver disease progression in Korean Americans living with chronic hepatitis B. Researchers will follow 365 participants over time, collecting health information and hair samples to measure stres…
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Cancer Treatment's hidden toll on sleep revealed in study
Knowledge-focused TerminatedThis study aimed to understand how head and neck cancer treatment affects patients' sleep quality over time. Researchers planned to survey patients at different stages of their treatment and recovery to identify factors that disrupt sleep. The goal was to gather information that …
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC
-
Researchers ask: why do people skip Life-Saving cancer tests?
Knowledge-focused TerminatedThis study aims to understand what helps or prevents people from getting screened for colorectal cancer, particularly in African American, Latinx, and Chinese communities. Researchers will conduct interviews and group discussions to learn about cultural beliefs and knowledge gaps…
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC